RICCIOLI, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 2.007
EU - Europa 672
AS - Asia 229
AF - Africa 30
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.956
Nazione #
US - Stati Uniti d'America 1.993
IT - Italia 298
SE - Svezia 150
IN - India 122
CN - Cina 82
UA - Ucraina 59
FI - Finlandia 54
TG - Togo 29
BE - Belgio 26
DE - Germania 24
GB - Regno Unito 18
IE - Irlanda 17
AR - Argentina 16
CA - Canada 14
FR - Francia 10
IR - Iran 10
MY - Malesia 7
RO - Romania 6
TR - Turchia 5
CH - Svizzera 3
NL - Olanda 3
EU - Europa 2
AL - Albania 1
BG - Bulgaria 1
DK - Danimarca 1
HK - Hong Kong 1
JP - Giappone 1
RS - Serbia 1
SG - Singapore 1
ZA - Sudafrica 1
Totale 2.956
Città #
Chandler 265
Fairfield 248
Rome 130
Woodbridge 116
Ashburn 113
Seattle 100
Wilmington 99
Ann Arbor 95
Houston 95
Cambridge 93
Princeton 72
Dearborn 66
Beijing 58
Fremont 56
Plano 56
San Paolo di Civitate 42
Millbury 40
Lawrence 39
Lomé 29
Boston 25
Brussels 22
San Diego 20
Andover 19
Jacksonville 19
Dublin 17
Federal 16
Washington 15
Norwalk 14
Des Moines 13
Boardman 12
Casoria 10
Milan 10
Sacramento 10
Göttingen 9
Bremen 7
Ottawa 7
Torino 7
Kunming 6
Leawood 5
Perugia 5
Toronto 5
Falls Church 4
Florence 4
Los Angeles 4
San Mateo 4
Bursa 3
Jinan 3
Nanchang 3
Nanjing 3
Zanjan 3
Ankara 2
Campobasso 2
Catania 2
Chongqing 2
Genova 2
Guidonia 2
Hefei 2
Itri 2
Kish 2
New York 2
Padova 2
Phoenix 2
San Giacomo Degli Schiavoni 2
Sezze 2
Yellow Springs 2
Anagni 1
Auburn Hills 1
Avellino 1
Belgrade 1
Bergamo 1
Bracciano 1
Cachan 1
Castellammare Di Stabia 1
Centrale 1
Chicago 1
Chiswick 1
Feletto Umberto 1
Fuzhou 1
Grafing 1
Gualtieri 1
Hanover 1
Kashan 1
L'aquila 1
Lappeenranta 1
Laurel 1
Melegnano 1
Montréal 1
Mountain View 1
Muizenberg 1
Nagpur 1
Palermo 1
Poggio Mirteto 1
Redmond 1
Redwood City 1
San Francisco 1
San Jose 1
Segrate 1
Sofia 1
Strasbourg 1
Suceava 1
Totale 2.181
Nome #
ISTOLOGIA di Monesi 102
Stem-like and highly invasive prostate cancer cells expressing CD44v8-10 marker originate from CD44-negative cells 89
Transfected poly(I:C) activates different dsRNA receptors leading to apoptosis or immunoadjuvant response in androgen-independent prostate cancer cells 87
Killing cancer cells using nanotechnology: novel poly(I:C) loaded liposome-silica hybrid nanoparticles 86
INFLAMMATORY MEDIATORS INCREASE SURFACE EXPRESSION OF INTEGRIN LIGANDS, ADHESION TO LYMPHOCYTES, AND SECRETION OF INTERLEUKIN 6 IN MOUSE SERTOLI CELLS 84
Mouse Sertoli cells display phenotypical and functional traits of antigen-presenting cells in response to interferon gamma 79
Sertoli cells initiate testicular innate immune responses through TLR activation 74
Presence of membrane and soluble forms of Fas ligand and of matrilysin (MMP-7) activity in normal and abnormal human semen 71
Mouse Sertoli Cells Sustain De Novo Generation of Regulatory T Cells by Triggering the Notch Pathway Through Soluble JAGGED1 68
The Fas system in the seminiferous epithelium and its possible extra-testicular role 66
FLIP is expressed in mouse testis and protects germ cells from apoptosis 66
Germ cell apoptosis control during spermatogenesis 65
ELECTROSTATIC INTERACTIONS IN THE EARLY EVENTS OF VSV INFECTION 64
Immunosuppressive molecules produced by Sertoli cells cultured in vitro: biological effects on lymphocytes. 63
A combination of hypoxia-inducible factor-1 inhibitors and toll-like receptor-3 agonists for treating solid tumours 62
TLR stimulation of prostate tumor cells induces chemokine-mediated recruitment of specific immune cell types 62
Structural characterization of cationic liposome/poly(I:C) complexes showing high ability in eliminating prostate cancer cells 61
ACTIVATION OF INOSITOL PHOSPHOLIPID TURNOVER AND CALCIUM SIGNALING IN RAT SERTOLI CELLS BY P2-PURINERGIC RECEPTORS - MODULATION OF FOLLICLE-STIMULATING-HORMONE RESPONSES 60
null 60
Peculiar Subcellular Localization of Fas Antigen in Human and Mouse Spermatozoa 59
The adherent/invasive escherichia coli (AIEC) strain LF82 invades and persists in human prostate cell lineRWPE-1 activating a strong inflammatory response 59
Circular RNAs in embryogenesis and cell differentiation with a focus on cancer development 59
Features of uropathogenic escherichia coli able to invade a prostate cell line 58
Effect of polyethyleneglycol (PEG) chain length on the bio–nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells 56
TOLL-LIKE RECEPTOR 3 REGULATES ANGIOGENESIS AND APOPTOSIS IN PROSTATE CANCER CELL LINES THROUGH HYPOXIA INDUCIBLE FACTOR-1α 54
Time Evolution of Nanoparticle-Protein Corona in Human Plasma: Relevance for Targeted Drug Delivery 54
HIF-1 activation by Toll Like Receptor-3 agonist poly (I:C) in prostate cancer cell line. 53
The role of autophagy in osteoclast differentiation and bone resorption function 53
Toll-like receptor 3 activation induces antiviral immune responses in mouse sertoli cells 53
CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells 46
TLR3 engagement induces IRF-3-dependent apoptosis in androgen-sensitive prostate cancer cells and inhibits tumour growth in vivo 45
MECHANISMS OF IMMUNE TOLERANCE IN THE TESTIS: INFLUENCE OF LOCAL FACTORS 44
null 44
Toll-Like Receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-a dependent mechanism 44
LOCALIZZAZIONE DELLE METALLOPROTEASI MMP-2 E MMP-9 NELL’EPITELIO SEMINIFERO 43
Espressione del Fasl nelle cellule germinali della gonade maschile. 43
Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression 41
Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation 41
Relevance of lysosomal Ca2+ signalling machinery in cancer 41
Programmed Death Ligand-1 (PD-L1), a family member involved in regulating T cell activation and tolerance, is expressed by Sertoli and peritubular smooth muscle cells. 40
Immunology and immupathology of male genital tract. Control and impairment of immune privilege in the testis and in semen 39
TESTICULAR FAS-LIGAND IS EXPRESSED BY SPERM CELLS 37
Role of P2-purinergic receptors in the regulation of the endocrine control of Sertoli cell activity 37
A proteomics-based methodology to investigate the protein corona effect for targeted drug delivery. 37
A role for PD-L1 in establishing immune privilege in the testis 34
Local regulation of testicular immune response 34
Toll-like receptors in prostate infection and cancer between bench and bedside 32
Characterization of signaling pathways leading to Fas expression induced by TNF-alpha: pivotal role of NF-kappaB 32
COMBINAZIONE DI INIBITORI DEL FATTORE HIF-1 E AGONISTI DEL RECETTORE TLR3 PER LA TERAPIA DI TUMORI SOLIDI 31
Molecular analysis of poly(I:C)-induced antitumor effects in androgen-independent prostate cancer cells 31
Proprietà invasive in cellule prostatiche e profilo di virulenza di Escherichia coli isolati da infezione del tratto urinario in pazienti comunitari 31
Toll-iike receptor-3 activation enhances malignant traits in human breast cancer cells through hypoxia-inducible factor-1α 31
TUMOR NECROSIS FACTOR-ALPHA INDUCES INTERLEUKIN-6 PRODUCTION AND INTEGRIN LIGAND EXPRESSION BY DISTINCT TRANSDUCTION PATHWAYS 28
The roles of Fas system in the testis 27
Localizzazione del ligando di Fas nelle cellule germinali della gonade maschile 27
Expression and function of Toll Like Receptor 3 in Sertoli cells. 26
Ruolo delle MAP chinasi nell’induzione di Fas mediata dal TNF- 26
TNF-alpha and IFN-gamma Regulate Expression and Function of the Fas System in the Seminiferous Epithelium. 25
Sertoli cell conditioned medium induces FoxP3 expression in mouse CD4+ T lymphocytes. 25
TNF-ALPHA INDUCES SURFACE MODIFICATIONS IN MOUSE SERTOLI CELLS: PHYSIOPATHOLOGICAL IMPLICATIONS 24
Toll Like Receptor activation induces cytokine upregulation in human prostate cancer cells 22
Two distinct antitumor patwways activated by transfected poly(I:C) in androgen-independent prostate cancer cells 20
Toll Like Receptor-3 and Sertoli cell signaling 17
The Fas system in the testis”. European Meeting of Immunology and Reproduction 16
Radioresistance Mechanisms in Prostate Cancer Cell Lines Surviving Ultra-Hypo-Fractionated EBRT: Implications and Possible Clinical Applications 14
ERK signaling pathway is constitutively active in NT2D1 non-seminoma cells and its inhibition impairs basal and HGF-activated cell proliferation 8
The PI3K/AKT pathway is activated by HGF in NT2D1 non‐seminoma cells and has a role in the modulation of their malignant behavior 8
The PI3K/AKT pathway is activated by HGF in NT2D1 non-seminoma cells and has a role in the modulation of their malignant behavior 6
Testosterone-mediated activation of androgenic signalling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines 5
null 3
Immunology and immunopathology of the male genital tract: Control and impairment of immune privilege in the testis and in semen 1
Relevance of lysosomal Ca2+ signalling machinery in cancer 1
Radioresistance Mechanisms in Prostate Cancer Cell Lines Surviving Ultra-Hypo-Fractionated EBRT: Implications and Possible Clinical Applications 1
Totale 3.135
Categoria #
all - tutte 6.283
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 164
selected - selezionate 0
volume - volumi 0
Totale 6.447


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019291 0 0 35 8 0 4 6 4 11 45 94 84
2019/2020642 99 13 10 30 47 106 80 62 63 58 53 21
2020/2021318 25 25 7 11 11 95 6 34 30 37 26 11
2021/2022691 12 31 62 52 75 13 15 87 54 53 124 113
2022/2023825 149 169 39 115 85 73 34 35 82 15 18 11
2023/2024151 56 66 29 0 0 0 0 0 0 0 0 0
Totale 3.135